For its first fiscal quarter (ending March 31), Blackstone Inc (NYSE: BX) has reported E.P.S. of $1.12 compared to $0.12 a year ago. For the latest four quarters through March 31, E.P.S. were $2.84 versus […]
Berkshire Hills Bancorp Inc (NYSE: BHLB) has reported a loss for its first fiscal quarter (ending March 31) of $-0.47 versus $0.63 for the same period a year ago. For the latest four quarters through […]
Ally Financial Inc (NYSE: ALLY) has reported E.P.S. of $0.42 for its first fiscal quarter (ending March 31) versus $0.96 for the same period a year ago. For the latest four quarters through March 31, […]
Texas Capital Bancshares Inc (NASDAQ: TCBI) has reported earnings for its first fiscal quarter (ending March 31) of $0.46 versus $0.70 for the same period a year ago. For the latest four quarters through March […]
On 4/18/24, SilverSun Technologies Inc (NASDAQ: SSNT) stock suffered a major decline of -11.5%, closing at $13.80. However, trading volume in this decline was normal at 83% of normal. The stock has risen 9.3% during […]
Independent Bank Corp. (NASDAQ: INDB) has reported earnings for its first fiscal quarter (ending March 31) of $1.12 versus $1.36 for the same period a year ago. For the latest four quarters through March 31, […]
For its first fiscal quarter (ending March 31), Glacier Bancorp Inc (NYSE: GBCI) has reported E.P.S. of $0.29 compared to $0.55 a year ago. E.P.S. were $1.75 for the latest four quarters through March 31 […]
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) stock closed at $17.50 on 4/18/24 after a major decline of -16.4%. Moreover, this decline was accompanied by exceptionally high trading volume at 451% of normal. Relative to the market […]
Chemung Financial Corp (NASDAQ: CHMG) has reported E.P.S. of $1.48 for its first fiscal quarter (ending March 31) versus $1.54 for the same period a year ago. For the latest four quarters through March 31, […]
BlueLinx Holdings Inc (NYSE: BXC) suffers from extremely meaningful negative changes in investment behavior: negative upside/downside volume developed, and its shorter term price trend turned down. Recent notable negative changes in fundamentals have affected BlueLinx […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research